A study finds that the antiviral drug is safe to prescribe in children with COVID-19 who are at least 6 years old.

​Pfizer-developed Paxlovid is a combination of two medicines. Nirmatrelvir, which blocks a key viral enzyme needed for ...

Pfizer’s antiviral COVID-19 treatment Paxlovid is safe and effective at treating adults with mild to moderate COVID-19 who are at high risk of progressing to severe disease, including hospitalization ...

In a clinical trial conducted by Stanford Medicine investigators and their colleagues, a 15-day course of Paxlovid—an antiviral drug combination targeting SARS-CoV-2, the virus that causes ...

Please provide your email address to receive an email when new articles are posted on . Paxlovid made no significant improvement to long COVID symptoms, including fatigue, brain fog and body aches.

In a clinical trial conducted by Stanford Medicine investigators and their colleagues, a 15-day course of Paxlovid - an antiviral drug combination targeting SARS-CoV-2, the virus that causes COVID-19 ...

Paxlovid is an antiviral therapy that helps your body fight off COVID-19 faster and more effectively. In one clinical trial, Paxlovid was 89% effective in reducing hospitalization and death in ...

Paxlovid, effective in preventing severe COVID-19, didn't appear to help long-COVID patients in this single-center study. But further research may show benefits with different doses or for people with ...